Pharmacokinetics of IAsp Following CSII in Patients With T1DM

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

Insulin Aspart (IAsp)

"IAsp 100 U.~≈ bolus protocol: From 6 pm until 6 am~• 50 % of habitual 24 hour insulin need/24 hours = basal rate (per hour)~From 8 am until 6 pm~1 dose/h + 50 % s.c. (≈ bolus)."

DRUG

Insulin Aspart (IAsp).

"IAsp 100 U From 6 pm until 8 am~• 50 % of habitual 24 hour insulin need/24 hours = basal rate (per hour)~From 8 am until 6 pm 50 % increase of basal rate"

DRUG

Insulin Aspart (IAsp)

"IAsp 100 U From 6 pm until 8 am~• 50 % of habitual 24 hour insulin need/24 hours = basal rate (per hour)~From 8 am until 6 pm 50 % increase of basal rate"

Trial Locations (1)

8000

Medicinsk Endokrinologisk Afdeling M, Aarhus C

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT00497536 - Pharmacokinetics of IAsp Following CSII in Patients With T1DM | Biotech Hunter | Biotech Hunter